Interleukin 2 deficiency induces bone destruction associated with dysregulation of the Rank/Rank Ligand/Osteoprotegerin system.

被引：0
|
作者：
Ashcroft, AJ
Lippitt, JM
Perry, MJ
Rollinson, SJ
Croucher, PI
Carding, SR
Morgan, GJ
机构：
[1] Univ Leeds, Acad Unit Haematol & Oncol, Leeds LS2 9JT, W Yorkshire, England
[2] Univ Leeds, Sch Biochem & Mol Biol, Leeds LS2 9JT, W Yorkshire, England
[3] Univ Sheffield, Dept Genom Med, Sheffield S10 2TN, S Yorkshire, England
[4] Univ Bristol, Sch Vet, Bristol BS8 1TH, Avon, England
[5] Univ Oxford, Nuffield Dept Orthopaed Surg, Oxford, England
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3403
引用
收藏
页码：819A / 819A
页数：1
相关论文
共 50 条
  • [1] RANK ligand and osteoprotegerin in myeloma bone disease
    Sezer, O
    Heider, U
    Zavrski, I
    Kühne, CA
    Hofbauer, LC
    BLOOD, 2003, 101 (06) : 2094 - 2098
  • [2] Estrogens and the osteoprotegerin/RANK-ligand system
    Hofbauer, LC
    Viereck, V
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (07) : 1287 - 1287
  • [3] Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
    Li, Xiaodong
    Ominsky, Michael S.
    Stolina, Marina
    Warmington, Kelly S.
    Geng, Zhaopo
    Niu, Qing-Tian
    Asuncion, Frank J.
    Tan, Hong-Lin
    Grisanti, Mario
    Dwyer, Denise
    Adamu, Steven
    Ke, Hua Zhu
    Simonet, W. Scott
    Kostenuik, Paul J.
    BONE, 2009, 45 (04) : 669 - 676
  • [4] Expression of osteoprotegerin and RANK ligand in breast cancer bone metastasis
    Park, HR
    Min, SK
    Cho, HD
    Kim, DH
    Shin, HS
    Park, YE
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2003, 18 (04) : 541 - 546
  • [5] Advances in ostheochlast biology:: the osteoprotegerin-RANK ligand system
    Muñoz-Torres, M
    López-Frías, MDL
    García, DF
    MEDICINA CLINICA, 2004, 122 (02): : 75 - 77
  • [6] RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
    Schoppet, M
    Preissner, KT
    Hofbauer, LC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (04) : 549 - 553
  • [7] Bone turnover after liver transplantation:relative contribution of bone markers and osteoprotegerin/RANK-Ligand system
    Martinez, G.
    Guadalix, S.
    Vargas, C.
    Cobaleda, B.
    Canillas, B.
    Jodar, E.
    Medeu, J.
    Moreno, E.
    Hawkins, F.
    CALCIFIED TISSUE INTERNATIONAL, 2008, 82 : S87 - S88
  • [8] Osteoprotegerin/rank ligand profile related to decreased bone turnover in cushing syndrome
    Galusca, B.
    Lindner, B.
    Germain, N.
    Hawa, G.
    Frere, D.
    Estour, B.
    BONE, 2009, 44 (02) : S278 - S279
  • [9] Effects of osteoprotegerin, RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head
    Xiong, Ming-Yue
    Liu, Li-Qiang
    Liu, Shi-Qiong
    Liu, Zhen-Hui
    Gao, Hang-Fei
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2016, 8 (07): : 3133 - 3140
  • [10] RANK Ligand: A Key Role in Cancer-Induced Bone Destruction?
    Stenzl, Arnulf
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (11) : 823 - 828
12345